All Stories

  1. Arsenic sulfide induces miR-4665-3p to inhibit gastric cancer cell invasion and migration

    Article • Drug Design Development and Therapy, August 2019, Taylor & Francis

    Dr Siyu Chen

  2. Arsenic sulfide amplifies JQ1 toxicity via mitochondrial pathway in gastric and colon cancer cells

    Article • Drug Design Development and Therapy, November 2018, Dove Medical Press

    Dr Siyu Chen

  3. Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth

    Article • Drug Design Development and Therapy, October 2015, Dove Medical Press

    Dr Siyu Chen

  4. Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo

    Article • Drug Design Development and Therapy, October 2015, Dove Medical Press

    Dr Siyu Chen, Dr Sungkyoung Kim

  5. Arsenic sulfide, the main component of realgar, a traditional Chinese medicine, induces apoptosis of gastric cancer cells in vitro and in vivo

    Article • Drug Design Development and Therapy, December 2014, Taylor & Francis

    Dr Siyu Chen

  6. Clinical response to sunitinib as a multitargeted tyrosine-kinase inhibitor (TKI) in solid cancers: a review of clinical trials

    Article • OncoTargets and Therapy, May 2014, Taylor & Francis

    Dr Siyu Chen, Dr Sungkyoung Kim